Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Michael Keller

Assistant Professor

George Washington University

United States

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

60%

Virology

70%

T Cell Biology

50%

Immunotherapy

50%

Stem Cell Transplantation

40%

Antiviral Therapy

40%

Pediatric Hematology

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES)

Open Date: 2018-06-01

Close Date: 2022-06-01

Grant: Close

Adoptive Immunotherapy for the Treatment of Viral Infections in Primary Immunodeficiency Disorders

Open Date: 2017-04-01

Close Date: 2020-03-31

Articles9

Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study

Article Link

Year:

2025

Multi-Year Registry Study of Elapegademase Treatment in Patients With Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Requiring Enzyme Replacement Therapy

Article Link

Year:

2025

Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant

Article Link

Year:

2024

Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy

Article Link

Year:

2024

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Article Link

Year:

2024

Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication

Article Link

Year:

2024

Third-Party and Patient-Specific Donor-Derived Virus-Specific T Cells Demonstrate Similar Efficacy and Safety for Management of Viral Infections after Hematopoietic Stem Cell Transplantation in Children and Young Adults

Article Link

Year:

2023

SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.

Article Link

Year:

2020

Virus-specific T-cell therapies for patients with primary immune deficiency

Article Link

Year:

2020

Collaborators7

Paibel Aguayo-HIraldo

Assistant Professor /Clinical director Transplant and Cellular Therapy

University of Southern California

UNITED STATES

Christopher Lazarski

Assistant Professor

George Washington University

UNITED STATES

Thomas Galletta

Assistant Professor of Clinical Pediatrics

Cincinnati Children's Hospital Medical Center

UNITED STATES

Satiro De Oliveira

Associate Professor

UNITED STATES

Shanmuganathan Chandrakasan

Emory University School of Medicine

UNITED STATES

Patrick Hanley

Associate Professor

George Washington University

UNITED STATES

Michael S. Grimley

University of Cincinnati College of Medicine

UNITED STATES

How do I reach out?

Meet Kite AI